The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

FDA approves Neffy 1 mg for children aged 4+ weighing 15 to <30 kg for allergic reactions. Most insured patients can access Neffy for $25, while cash price is $199 for two doses. Get our list of ...

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to 30 Kilograms ...

March 6, 2025 – The FDA has approved a new nose spray that can quickly treat severe allergic reactions in kids ages 4 and up. This is the first emergency treatment that doesn’t use a needle.

The FDA has approved Archimedes Pharma’s Lazanda nasal spray for the management of breakthrough pain in adult cancer patients, according to a report by the FDA. Breakthrough pain in cancer is an ...

The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults ...

TUESDAY, June 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device for at-home treatment of ...